nach oben

Child's Nervous System

Erschienen in:

01.09.2007 | Special Annual Issue

Nonoperative management of spasticity in children

verfasst von: Susan Ronan, Joan T. Gold

Erschienen in: Child's Nervous System | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Central to the longitudinal management of childhood hypertonia are nonsurgical treatments. These include physical and occupational therapy, electrical stimulation, orthotics, botulium toxin, and drugs. This manuscripts reviews these treatment modalities as well as evaluation tools available to assess their impact on a child’s hypertonia.

Abel MF, Juhl GA, Vaughn CL, Damiano DL (1998) Gait assessment of fixed ankle-foot orthoses in children with spastic diplegia. Arch Phys Med Rehabil 79:126–133PubMed

Albright AL, Awaad Y, Muhonan M, Boydston WK, Gilmartin R, Krach LE, Turner M, Zidek KA, Wright E, Swift D, Bloom K (2004) Performance and complications associatied with the Synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101(1 Suppl):64–68PubMed

Allison SC, Abraham LD (2001) Sensitivity of qualitative and quantitative measures to clinical treatment with cryotherapy. Int J Rehabil Res 24(1):15–24PubMed

Andersson C, Grootern W, Hellsten M, Kaping K, Mattsson E (2003) Adults with cerebral palsy: walking ability after progressive strength training. Dev Med Child Neurol 45(4):220–228PubMed

Ansari NN, Adelmanesh F, Naghdi S, Tabtabaei A (2006) The effect of physiotherapeutic ultrasound on muscle spasticity in patients with hemiplegia: a pilot study. Electromyogr Clin Neurophysiol 46(4):247–252PubMed

Ansved T, Odergren T, Borg K (1997) Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment in cervical dystonia. Neurology 48:1440–1442PubMed

Arens LJ, Goldschmidt RB, Leary PM (1997) Botulinum toxin A in the hemiplegic upper extremity. Dev Med Child Neurol 39:185–193

Autti-Ramo I, Suoranta J, Anttila H, Malmivaara A, Makela M (2006) Effectiveness of upper and lower limb casting and orthoses in children with cerebral palsy: an overview of review articles. Am J Phys Med Rehabil 85:89–103PubMed

Bar-Haim S, Harries N, Belokopytov H, Frank A, Copeliovitch L, Kaplanski I, Lahat E (2006) Comparison of efficacy of Adeli suit and neurodevelopmental treatment in children with cerebral palsy. Dev Med Child Neurol 48(6):325–330PubMed

10.

Barry M, Albright L, Shultz B (2000) Intrathecal Baclofen therapy and the role of the physical therapist. Pediatr Phys Ther 12(2):77–86

11.

Battin MR, Dezoete JA, Gunn TR, Gluckman PD, Gunn AJ (2001) Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatr 107:480–484

12.

Bayram S, Sivriogllu K, Karli N, Ozcan O (2006) Low-dose botulinum toxin with short-term electrical stimulation in post stroke spastic drop foot: a preliminary study. Am J Phys Med Rehabil 85(1):75–81PubMed

13.

Bertolli DB (1986) Effect of short leg casting on ambulation in children with cerebral palsy. Phys Ther 66:1522–1529

14.

Bleck EE (1987) Orthopedic management of cerebral palsy. Clinical developmental medicine, vol. 99/100. MacKeith, Oxford

15.

Bobath K (1980) A neurophysiologic basis to the treatment of cerebral palsy. Spastics International, Laveham, UK

16.

Bohannon RW, Smith MB (1987) Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 67:206–207PubMed

17.

Booth MY, Yates CC, Edgar TS, Bandyu WD (2003) Serial casting vs. combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther 15(4):216–220PubMed

18.

Bottos M, Benedetti MG, Salucci P, Gasparroni V, Gianni S (2003) Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol 45(11):758–762PubMed

19.

Brouwer B, Wheeldon RK, Stradiotto-Parker N, Allum J (1998) Reflex ecitability and isometric force production in cerebral palsy: the effect of serial casting. Dev Med Child Neurol 40(3):168–175PubMedCrossRef

20.

de Bruin H, Russell DJ, Latter JE, Sadler JT (1982) Angle-angle diagrams in monitoring and quantification of gait patterns in children with cerebral palsy. Am J Phys Med 61:176–192PubMed

21.

Burtner PA, Woollacott MH, Qualls C (1999) Stance balance control with orthoses in a group of children with spastic cerebral palsy. Dev Med Child Neurol 41(11):748–757PubMed

22.

Capute AJ (1978) Primitive reflex profile. University Park Press, Baltimore

23.

Carda S, Molteni F (2005) Taping versus electrical stimulation after botulinum type A injection for wrist and finger spasticity. A case–control study. Clin Rehabil 19(6):621–626PubMed

24.

Carlson WE, Vaughn CL, Damiano DL, Abel MF (1997) Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil 76(3):219–225PubMed

25.

Carmick C (1997) Use of neuromuscular electrical stimulation and a dorsal wriest splint to improve hand function of a child with spastic hemiparesis. Phys Ther 77(6):661–671PubMed

26.

Childers MK, Biswass S, Petroski G, Merveille O (1999) Inhibitory casting decreases a vibratory inhibition index of the H-reflex in the spastic upper-limb. Arch Phys Med Rehabil 84:483–491

27.

Chin TY, Nattrass GR, Selber P, Graham HK (2005) Accuracy of intramuscular injection of Botulinum Toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25:286–291PubMed

28.

Chu ML, Sala DA (2006) The use of tiagabine in pediatric spasticity management. Dev Med Child Neurol 48(6):456–459PubMed

29.

Clopton N, Dutton J, Featherston T, Grigsby A, Mobley J, Melvin J (2005) Interrater and intrarater reliability of the Modified Ashworth Scale in children with hypertonia. Pediatr Phys Ther 17(4):268–274PubMed

30.

Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK (1998) Botulinum Toxin A compared with stretching casts in the treatment of spastic equinus: a randomized prospective trial. J Pediatr Orthop 18:304–311PubMed

31.

Cosgrove AP, Graham HK (1991) Botulinum toxim A presents the development of contractures isn the hereditary spastic mouse. Dev Med Child Neurol 33:730–736

32.

Costa J, Borges A, Espirito-Santo C, Ferreira J, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev 25(1):CD004314 (Review)

33.

Crenshaw S, Herzog R, Castagno P, Richards J, Miller F, Michaloski GC, Moran E (2000) The efficacy of tone-reducing splints in children with spastic diplegic cerebral palsy. J Pediatr Orthop 20(2):210–216PubMed

34.

Damiano DL, Vaughan CL, Abel MF (1995) Muscle response to heavy resistance exercise in children with spastic cerebral palsy. Dev Med Child Neurol 37:731–739PubMedCrossRef

35.

Damiano DL, Gilgannon MD, Abel MF (2005) Responsiveness and uniqueness of the Pedaitric Outcomes Data Collection Instrument compared to the Gross Motor Function Measure for measuring orthopedic and neurosurgical outcomes in cerebral palsy. J Pediatr Orthop 25(5):641–645PubMed

36.

Diachman J, Johnston TE, Evans K, Tecklin JS (2003) The effects of a neuromuscular electrical stimulation home program on impairments and functional skills of a child with spastic diplegic cerebral palsy: a case report. Pediatr Phys Ther 15(3):153–158

37.

Dimitrijevic M, Stokic D, Wun C (1996) Modification of motor control of wrist extension by mesh-glove electrical afferent stimulation in stroke patients. Arch Phys Med Rehabil 77(3):252–258PubMed

38.

Duncan B, Barton L, Edmonds D, Blashill BM (2004) Parental perceptions of the therapeutic efficacy of osteopathic manipulation or acupuncture in children with spastic cerebral palsy. Clin Pediatr 43(4):349–353

39.

Duncan WR (1960) Tonic reflexes of the foot. J Bone Jt Surg 42-A(75):859–868

40.

Dursen E, Dursen N, Alican D (2004) Effects of biofeedback treatment on gait in children with cerebral palsy. Disabil Rehabil 26(2):116–120

41.

Eliasson AC, Krumlinde-suncholm L, Shaw K, Wang C (2005) Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adaptive model. Dev Med Child Neurol 47(4):266–275PubMed

42.

Engle H (1966) The effect of diazepam (Valium) in children with cerebral palsy: a double-blind study. Dev Med Child Neurol 8:661–667PubMedCrossRef

43.

Farmer SF, Harrison LM, Ingram DA, Stephens JA (1991) Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology 41:1505–1510PubMed

44.

Fatagi Y, Abe J (1985) H-reflex study in normal children and patients with cerebral palsy. Brain Develop 7(4):414–420

45.

Feldman AB, Haley SM, Coryell J (1990) Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther 70:602–610PubMed

46.

Fetters L, Figueiredo EM, Keane-Miller D, McSwenneny DJ, Tsao C (2004) Constraint induced therapy (??). Pediatr Phys Ther 16(1):77–79

47.

Fowler EG, Ho TW, Nwigwe AI, Dorey FJ (2001) The effect of quadriceps femoris muscle strengthening exercises on spasticity in children with cerebral palsy. Phys Ther 81(6):1215–1223PubMed

48.

Friden J, Lieber R (2003) Spastic muscle cells are short and stiffer than normal cells. Muscle Nerve 26:157–164

49.

Gage JR (1993) Gait analysis: an essential tool in the treatment of cerebral palsy. Clin Orthop 288:126–134PubMed

50.

Galvin KA (1998) Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxic/ischemia in the rate. Pediatr Res 44:740–745PubMed

51.

Glanzman AM, Kim H, Swaminathan K, Beck T (2004) Efficacy of botulinum toxin A, serial casting, and combine treatment for spastic equinus: a retrospective analysis. Dev Med Child Neurol 46(12):807–811PubMed

52.

Goldstein EM (2006) Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol 21(3):189–192PubMed

53.

Gormley ME, Gaebler-Spira D, Delgado MR (2001) Use of botulinum type A in pediatric patients with cerebral palsy. A three-center retrospective chart review. J Child Neurol 16:113–118PubMed

54.

Gosechel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H (1997) Botulinum A toxin therapy: neutralizing and non-neutralizing antibodies—therapeutic consequences. Exp Neurol 147:96–102

55.

Gracies J, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacologic treatment for spasticity. Part II. General and regional treatment. Muscle Nerve Suppl 6:100

56.

Granger CV (1987) Guide for the use of the Functional Independence Measure for Children (WeeFIM) of the uniform data set for medical rehabilitation. Research Foundation, State University of New York, Buffalo, NY

57.

Graham HK, Harvey A, Rodda J, Nattrass GR, Pirpiris M (2004) The functional mobility scale. J Pediatr Orthop 24(5):514–520PubMed

58.

Guyatt G, Sackett D, Taylor DW, Chong J, Roberts R, Pugsley S (1986) Determining optimal therapy: randomized trials in individual patients. N Engl J Med 314:889–892PubMedCrossRef

59.

Haley SM, Ludlow LH, Coster WJ (1993) Pediatric evauation of disability inventory. Phys Med Rehabil North Am 4(3):529–540

60.

Halpern D, Meelhuysen FE (1982) Duration of relaxation after intramuscular neurolysis with phenol. JAMA 247:1473–1476

61.

Hansel DE, Hansel CRW, Shinale MK, Reinhardt EM, Madden L, Levey EB, Johnston MV, Hoon AH (2003) Oral baclofen in cerebral palsy: possible seizure potentiation. Pediatr Neurol 29(3):203–206PubMed

62.

Hazneci B, Tan AK, Guncikan MN, Dincer K, Kalyon TA (2006) Comparison of the efficacies of boutlinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial. Mil Med 171(7):653–656PubMed

63.

Harris SR (1989) Early diagnosis of spastic diplegia, spastic hemiplegia and quadriplegia. Am J Dis Child 143:1353–1360

64.

Harrison A (1988) Spastic cerebral palsy: possible spinal interneuronal contributions. Dev Med Child Neurol 30:769–780PubMedCrossRef

65.

Haslam R, Walcher J, Lietman PS (1974) Dantrolene sodium in children with spasticity. Arch Phys Med Rehabil 55:384–387PubMed

66.

Hinderer KA, Harris SR, Purdy AH, Chew DE, Staheli LT, Mc Laughlin JF, Jaffe KM (1988) Effects of tone reducing versus standard palster cases of gait improvement in children with cerebral palsy. Dev Med Child Neurol 30:370–377PubMedCrossRef

67.

Hirtz DG, Nelson K (1998) Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr 10:131–137PubMed

68.

Hoving MA, van Kranen-Mastenbroek VHJM, van Raak EPM, Spincemaille GHJJ, Hardy ELM, Vies JSH (2006) Placebo controlled utility and feasiability study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol 117(7):1508–1517PubMed

69.

Huang H, Merver V, Thorpe D (2003) Effects of different concurrent cognitive tasks on temporal-distance gait variables in children. Pediatr Phys Ther 15:105–113PubMed

70.

Hurvitz EA, Leonard C, Ayyangar R, Nelson VS (2003) Complementary and alternative medicine use in families of children with cerebral palsy. Dev Med Child Neurol 45:364–370PubMed

71.

Karman N, Maryles J, Baker RW, Simpser E, Berger-Gross P (2003) Constraint-induced movement therapy for hemiplegic children with acquired brain injuries. J Head Trauma Rehabil 18(3):259–267PubMed

72.

Kassover M, Tauber C, Au J, Pugh J (1986) Auditory biofeedback in spastic diplegia. J Orthop Res 4:246–249PubMed

73.

Katrak PH, Cole AM, Poulos CJ, McCauley JC (1992) Objective assessment of spasticity, strength and function with early exhibition of Dantrolene sodum after cerebrovascular accident: a randomized double blind trial. Arch Phys Med Rehabil 73:4–9PubMed

74.

Katz RT, Campagnolo DI (1994) Pharmacologic management of spasticity. Phys Med Rehabil 8:473–480

75.

Kerem M, Livanelioglu A, Topcu M (2001) Effects of Johnstone pressure splints combined with neurodevelopmental therapy on spasticity and cutaneous sensory inputs in spastic cerebral palsy. Dev Med Child Neurol 43(5):307–313PubMed

76.

Khalili A, Betts HB (1967) Peripheral nerve block with phenol in the management of spasticity. JAMA 260(13):1155–1157

77.

Kilgoor G, McNair P, Stott NS (2003) Intrarater reliability of lower limb saggital range-of-motion measures in children with spastic diplegia. Dev Med Child Neurol 45(6):391–399

78.

Knutsson E, Mattsson E (1969) Effects of local cooling on monosynaptic reflexes in man. Scand J Rehabil Med 2:159–163

79.

Korman LA, Mooney JF, Smith B, Goodman A (1993) Management of cerebral palsy with Botulinum-A toxin: preliminary investigation. J Pediatr Orthop 13:489–495

80.

Krach LE (2001) Pharmacotherapy of spasticity: oral medications and intrathecal blacofen. J Child Neurol 16(1):31–36PubMed

81.

Lagalla G, Danni M, Reiter F, Ceravalo M, Provinciali L (2000) Post-stroke spasticity management with repeated botulinum toxin injection in the upper limb. Am J Phys Med Rehabil 79(4):377–384PubMed

82.

Lance JW (1980) Symposium synopsis. In: Fledman RG, Young RR, Koella WP (eds) Spasticity: disordered motor control. Yearbook, Chicago, pp 485–494

83.

Law M, Cadman D, Rosenbaum P, Walter S, Russell D, DeMatteo C (1991) Neurodevelopmental therapy and upper-extremity inhibitive casting for children with cerebral palsy. Dev Med Child Neurol 33:379–387PubMedCrossRef

84.

Lee JM, Warren MP, Mason SM (1978) Effects of ice on nerve conduction celocity. Physiotherapy 64:2–6PubMed

85.

Lehmann JF, Price R, deLateur BJ, Hinderer S, Traynor C (1989) Spasticity quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil 70:6–15PubMed

86.

The Little Club (1959) Memorandum on terminology and classification of “cerebral palsy”. Cereb Palsy Bull 1:27–35

87.

Maltais DB, Pierrynowski MR, Galea VA, Bar-Or O (2005) Physical activity level is associated with the O₂ cost of walking in cerebral palsy. Med Sci Sports Exerc 37(3):347–353PubMed

88.

Maltais D, Bar-Or O, Galea V, Pierrynowski M (2001) Use of orthoses lowers the O₂ cost of walking in children with spastic cerebral palsy. Med Sci Sports Exerc 33:320–325PubMed

89.

Mandac BR, Hrvitz EA, Nelson VS (1993) Hyperthermia associated with baclofen withdrawal and increased associated spasticity. Arch Phys Med Rehabil 74(1):96–97PubMed

90.

Mandigo CE, Anderson RCE (2006) Management of childhood spasticity: a neurosurgical percpective. Pediatr Ann 35(5):354–362PubMed

91.

Martin JE, Epstein LH (1976) Evaluating treatment effectiveness in cerebral palsy: single subject designs. Phys Ther 56(3):285–294PubMed

92.

Mayo NE (1991) The effect of physical therapy for children with motor delay and cerebral palsy. Am J Phys Med Rehabil 70:258–267PubMed

93.

Mathew A, Mathew C, Thomas M, Antonisamy B (2005) The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Med 51(2):109–113

94.

Miller VS (1993) Pharmacologic management of neonatal cerebral ischemia and hemorrhage: old and new directions. J Child Neurol 8:7–18PubMed

95.

Mills VM (1994) Electromyographic results of inhibitory splinting. Phys Ther 64:190

96.

Mooney JF, Koman LA, Smith BP (2003) Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop 23(5):679–686PubMed

97.

Msall ME, DiGaudio K, Rogers BT, LaForest S, Catanzaro NL, Campbell J, Wilczenski F, Duffy LC (1994) The Functional Independence Measure for Children (WeeFIM). Conceptual basis and pilot use in children with developmental disabilities. Clin Pediatr (Philadelphia) 33(7):421–430 (Review)

98.

Neilson PD, McCaughey J (1982) Self-regulation of spasm and spasticity in cerebral palsy. J Neurol Neurosurg Psychiatr 45:320–330PubMed

99.

Nelson KB (1989) Relationship of intrapartum and delivery events to long-term neurologic outcome. Clin Perinatol 16:995–1007PubMed

100.

Nogen AG (1979) Effectof dantrolene sodium on the incidence of seizures in children with spasticity. Child’s Brain 5(4):420–425PubMed

101.

Nordmark E, Anderson G (2002) Wartenberg pendulum test: objective quantification of muscle tone in children with spastic diplegia undergoing selective dorsal rhizotomy. Dev Med Child Neurol 44(1):26–33PubMed

102.

Nordmark E, Anderson G (2002) Wartenberg pendulum test: objective quantification of change in tone in children with spastic diplegia undergoing selective dorsal rhizotomy. Dev Med Child Neurol 44(1):26–33PubMed

103.

Nordmark E, Hagglund G, Jarnlo GB (1997) Reliability of the Gross Motor Function Measure in cerebral palsy. Scand J Rehabil Med 29:25–28PubMed

104.

Norkin C, White DJ (1985) Measure of joint motion: a guide to goniometry. FA Davis, Philadelphia

105.

Odeen I (1981) Reduction in muscular hypertonus by long-term muscle stretch. Scand J Rehabil Med 13:93–99PubMed

106.

Ottenbacher KJ, Biocca Z, DeCremer G, Gevelinger M, Jedlovec KB, Johnson MB (1986) Quantitative analysis of the effectiveness of pediatric therapy: emphasis on the neurodevelopmental treatment approach. Phys Ther 66:1095–1101PubMed

107.

Palmer FB, Shapiro BK, Wachtel RC, Allen MC, Hiller JE, Harryman SE, Mosher BS, Meinert CL, Capute AJ (1988) Effects of physical therapy on cerebral palsy. N Engl J Med 318:803–808PubMedCrossRef

108.

Pape KE, Kirsch SE, Galil A, Boulton JE, White A, Chipman M (1993) Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study. J Pediatr Orthop 13:628–633PubMed

109.

Parziale JR, Akelman E, Herz DA (1993) Spasticity: pathophysiology and management. Orthop 16(7):803–811

110.

Peterson T, Klemar B (1988) Electrical stimulation as a treatment in lower extremity spasticity. J Neurol Rehabil 2:103–108

111.

Pierce SR, Daly K, Gallagher KG, Gershkoff AM, Schaumburg SW (2002) Constraint-induced therapy for a child with hemiplegic cerebral palsy: a case report. Arch Phys Med Rehabil 83:1462–1463PubMed

112.

Pirpiris M, Graham HK (2004) Uptime in children with cerebral palsy. J Pediatr Orthop 24(5):521–528PubMed

113.

Pletzek UM, Heinen F, Schwerin A, Berweck S (2005) Botulinum treatment in children with spastic movement disorders: a pilot study. Pediatr Neurol 31:109–113

114.

Preissner KS (2001) The effects of serial casting on spasticity: a literature review. Occup Ther Health Care 14(2):99–106

115.

Reeuwojk A, van Shie PEM, Becher JG, Kwakkel G (2006) Effects of boutlinum toxin type A on upper limb function in children with cerebral palsy: a systematic review. Clin Rehabil 20(5):375–387

116.

Robinson RO (1973) The frequency of other handicaps in children with cerebral palsy. Dev Med Child Neurol 15:305–316PubMedCrossRef

117.

Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, Wood E, Barlett DJ, Galuppi BE (2002) Prognosis for gross motor function in cerebral palsy: Creation of Motor Development Curves. JAMA 288(11):1357–1363PubMed

118.

Russell D, Rosenbaum P, Cadman D, Gowland C, Hardy S, Jarvis S (1989) The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 31:341–352PubMedCrossRef

119.

Sala D, Grant AD (1995) Prognosis for ambulation in cerebral palsy. Dev Med Child Neurol 37:1020–1026PubMedCrossRef

120.

Salkorpi T, Sajaniemi N, Hällback H, Kari A, Rita H, Von Wendt L (1997) Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr 86:294–298

121.

Sanders JO, McConnell SL, King R, Landford A, Montpetit K, Gates P, Rich M, Shepard K, Cupp T, Haynes R, Bush P, Tahir F, Santiago J, Lighter DE, Smrcina C, Niederpruem ML, McDonald C, Curry DB (2006) A prospective evaluation of the WeeFIM in pareints with cerebral palsy undergoing orthopedic surgery. J Pediatr Orthop 26(4):542–546PubMed

122.

Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW, Task Force on Childhood Motor Disorders (2003) Classification and definitions of disorders causing hypertonia in children. Pediatrics 111:e89–e97PubMed

123.

Sankey RJ, Anderson DM, Young JA (1989) Characteristics of ankle-foot orthoses for management of the spastic lower limb. Dev Med Child Neurol 31:466–470PubMedCrossRef

124.

Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH, Beecher JG (2006) The combined effect of lower-limb multilevel Botlulinum Toxin type A and comprehensive rehabilitation of mobility in children with cerebral pals: a randomized clinical trial. Arch Phys Med Rehabil 87:1551–1558PubMed

125.

Semenova KA, Bobnova VA, Vinogradova LJ, Tikunova NP (1986) Cryotherapy in the complex restorative treatment of children with infantile cerebral palsy. Zh Nevropatol Psikhiatr Im SS Korsakova 86(10):1459–1463

126.

Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH, National Institute of Child Health and Human Development Neonatal Research Network (2005) Whole-body hypothermia for neonates with hypoxic–ischemic encephalopathy. N Engl J Med 353:1574–1584PubMed

127.

Singer BJ, Singer KP, Allison GT (2003) Evaluation of extensibility, passive torque and stretch reflex responses in triceps surae muscles following serial casting to correct spastic equinovarus deformity. Brain Inj 17(4):309–324PubMed

128.

Siracusa C, Taynor M, Geletka B, Overby A (2005) Effectiveness of biomechanical intervention in children with spastic diplegia. Pediatr Phys Ther 17(1):83–84

129.

Smelt HR (1989) Effect of an inhibitive weight-bearing mitt on tone reduction and functional performance in a child with cerebral palsy. Phys Occup Ther Pediatr 9(2):53–80PubMed

130.

Steinbok P (2006) Selection of treatment modalities in children with spastic cerebral palsy. Neurosurg Focus 21(2):e4PubMedCrossRef

131.

Sussman M (1979) Preliminary report: the role of short-leg tone reducing casts as an adjunct to physical therapy of patients with cerebral palsy. Johns Hopkins Med J 145:112–114PubMed

132.

Sutherland DH, Schottsteadt ER, Larsen LJ, Ashley RK, Callendar PM, James PM (1969) Clinical and electromyographic study of spastic children with internal rotation gait. J Bone Jt Surg 51-A(6):70–1082

133.

Tanaka H, Fukada I, Miyamoto A, Oka R, Cho K, Fujieda K (2004) Effects of tizanidine for refractory sleep disturbance in disabled children with spastic quadriparesis. No to Hattatsu 36(6):455–460PubMed

134.

Tardieu C, Huet de la Tour E, Bret MD, Tardieu G (1982) Muscle hypoextensibility in children with cerebral palsy. Arch Phys Med Rehabil 63:97–110PubMed

135.

Tardieu C, Lespargot A (1988) For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 30(1):3–10PubMedCrossRef

136.

Tardoff K (1986) Spontaneous remission in cerebral palsy. Neuropediatrics 17:19–22

137.

Taub E, Lum P, Hardin P, Mark V, Uswatte G (2005) AutoCITE automated delivery of CI therapy with reduced effort by therapists. Stroke 36:1301–1304PubMed

138.

Tirosh E, Rabino S (1989) Physiotherapy for children with cerebral palsy. Am J Dis Child 143:551–553

139.

Toner LV, Cook, Elder GCB (1998) Improved ankle function in children with cerebral palsy after computer-assisted motor learning. Dev Med Child Neurol 40:829–835PubMedCrossRef

140.

Tscharnuter I (2002) Clinical application of dynamic theory concepts according to Tscharnuter Akademie for Movement Organization (TAMO) therapy. Pediatr Phys Ther 14:29–37PubMed

141.

Tsorlakis N, Evaggelinou C, Grouios G, Tsorbatzoudis C (2004) Effect of intensive neurodevelopmental treatment in gross motor function of children with cerebral palsy. Dev Med Child Neurol 46(11):740–745PubMed

142.

Valvano J (2004) Activity-focused motor interventions for children with neurological conditions. Phys Occup Ther Pediatr 24(1):79–107PubMedCrossRef

143.

Verplankle D, Snape S, Salisbury CF, Jones PW, Ward AB (2005) A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil 19(2):117–125

144.

Verotti A, Greco R, Spalice A, Chiarelli F, Iannetti P (2006) Phamacotherpay of spasticity in children with cerebral palsy. Pediatr Neurol 34:1–6

145.

Wang R, Chan R, Tsai M (2000) Effects of thoraco-lumbar electrical sensory stimulation of knee extensor spasticity of persons who survived cerebrovascular accidents. J Rehabil Res Dev 37(1):73–79PubMed

146.

Wantabe T (2004) The role of therapy in spasticity management. Am J Phys Med Rehabil 84:S45–S49

147.

Watkins CA (1999) Mechanical and neurophysiological changes in spastic muscles: serial casting in spastic equinovarus following traumatic brain injury. Physiotheraphy 85(11):603–609

148.

Wei S, Su-Juan W, Yuan-Gui L, Hong Y, Xiu-Juan X, Xiao-Mei S (2006) Reliability and validity of the GMFM-66 in 0-to 3-year-old children with cerebral palsy. Am J Phys Med Rehabil 85(2):141–147PubMed

149.

Williams PE, Goldspink G (1978) Changes in sarcomere length and physiological properties in immobilized muscle. J Anat 127(3):459–468PubMed

150.

Wong E, Man D (2005) Gross Motor Function Measure for children with cerebral palsy. Int J Rehabil Res 28(4):355–359PubMed

151.

Wu YW, Colford JM Jr (2000) Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 284:1417–1427PubMed

152.

Young RR, Delwaide PJ (1981) Drug therapy: spasticity. N Engl J Med 304:28–43PubMedCrossRef

153.

Zarfonte R, Lomard L, Elovic E (2004) Antispasmoticity medications: uses and limitations of enteral therapy. Am J Phys Med Rehabil 83(10):s50–s66

154.

Ziv I, Blackburn N, Rang M, Koreska J (1984) Muscle growth in normal and spastic mice. Dev Med Child Neurol 26:94–99PubMedCrossRef

Titel: Nonoperative management of spasticity in children
verfasst von: Susan Ronan
Joan T. Gold
Publikationsdatum: 01.09.2007
Verlag: Springer-Verlag
Erschienen in: Child's Nervous System / Ausgabe 9/2007
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI: https://doi.org/10.1007/s00381-007-0396-4

Neu im Fachgebiet Chirurgie

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2007

Selective dorsal rhizotomy for spastic cerebral palsy: a review

Intrathecal baclofen for childhood hypertonia

Selective dorsal rhizotomy: long-term experience from Cape Town

Apoptosis in alpha interferon (IFN-α) intratumoral chemotherapy for cystic craniopharyngiomas

Joon-Uhn Choi: the 2005–2006 ISPN President

35th Annual Meeting of the International Society for Pediatric Neurosurgery, Liverpool, UK, 9–13 September 2007

Update Chirurgie